Venomous snakebite is a global serious health issue and in India high rate of mortality is caused by Naja naja (Indian cobra). To evaluate anti-cobra venom activity and identify lead molecules in Aegle marmelos, in vitro and in silico screening was carried out. Leaves, stem and root bark of A. marmelos were extracted in ethanol, methanol and hexane and maximum yield was obtained in methanol.

Original Source

The Global Burden of Disease Study (GBD) is generating important and often nonintuitive information about the prevalence, incidence, morbidity, and mortality of the world’s major communicable and noncommunicable diseases (NCDs). An emerging narrative from the GBD is the gradual ascendency of the NCDs, especially among the world’s large low- and middle-income countries (LMICs). But with regards to the neglected tropical diseases (NTDs), we have also seen how these chronic and debilitating infections of poverty might also account for a high percentage of the global disease burden.

The African Leaders Malaria Alliance (ALMA) - at the 30th African Union heads of state and government summit now under way in Addis Abba, Ethiopia - has added neglected tropical diseases (NTDs) to

Jaipur: At a time when dengue is taking its toll on the health of people, there is another disease having symptoms similar to dengue is being noticed by the doctors.

ZAMFARA, Nigeria (Thomson Reuters Foundation) - When six-year old Mohammed Waziga arrived at a health centre in northwest Nigeria complaining of joint pains and drowsiness, he was given an injectio

Medical samples from four of the victims of a disease in Liberia that initially baffled scientists have tested positive for a type of meningitis, the minister of health said on Monday.

WHO reports remarkable achievements in tackling neglected tropical diseases (NTDs) since 2007. An estimated 1 billion people received treatment in 2015 alone. WHO has observed record-breaking progress towards bringing ancient scourges like sleeping sickness and elephantiasis to their knees.

The UK will commit £450m ($563.5m) towards tackling the world's most infectious tropical diseases, such as Guinea worm disease and elephantiasis.

Global funding for research and development on neglected diseases reached a historic low in 2015, driven by declining public sector investment. The G-FINDER report by Australia-based independent group, Policy Cures Research, says that the decline is due to the lack of funding by rich countries. According to it, this is the lowest-ever funding on record by the US. Same can be said of the UK. The G-FINDER analysis tracks public and private investment in diseases that affect people in the developing countries. Over 1 billion people in 149 countries worldwide suffer from one or more neglected diseases, and they are now included in the Sustainable Development Goals.

Progress towards the elimination of a neglected tropical disease from a country can sometimes be a curse, especially when policymakers are confronted with competing needs and priorities. This could mistakenly be interpreted as though the disease has been eradicated, resulting in the limited resources becoming redirected to the next priority, sometimes leaving unfinished agendas. Much depends on whether the long term is considered in the elimination agenda and whether contingency plans are in place should the disease re-emerge as a public health problem.

Pages